SCALE Music City is proud to have Platinum Sponsor Ortho Dermatologics for SCALE 2020. Ortho Dermatologics is part of a long list of exhibitors and sponsors, including some of the top names in the fields of aesthetic medicine, cosmetic surgery and dermatology such as Allergan, Galderma, BTL, Merz Aesthetics, and many others.
Join us at SCALE 2020 to learn more about cutting edge dermatological advances from Ortho Dermatologics and our other esteemed exhibitors!
All About Ortho Dermatologics
Ortho Dermatologics is a company that cares. The mission statement of Ortho Dermatologics is “to become your most trusted source in the dermatology field through our honest actions and ongoing heritage of helping you improve patients’ lives.” Ortho Dermatologics backs up those words through a series of philanthropic efforts with students and in local communities around the world.
Ortho Dermatologics, alongside fellow SCALE Sponsor Solta Medical, is a subsidiary of Bausch Health. The combination of focus on prescription dermatological care and the backing of a major corporation like Bausch Health has allowed Ortho Dermatologics to become one of the foremost innovators in the dermatological space.
The Products of Ortho Dermatologics
“Ortho Dermatologics is committed to helping you assist the patients in your practice by offering a wide range of FDA-approved treatments.” A few of the well-known products from Ortho Dermatologics include:
ALTRENO® (tretinoin) Lotion, 0.05%
Altreno is “the first and only 0.05% tretinoin lotion, designed with her in mind.” Altreno is designed to tackle the many causes and symptoms of acne while simultaneously keeping patients’ skin looking and feeling its best. Many patients and physicians will understand that the side effects of many prescription acne medications are a big concern. Altreno is designed to be both gentle and effective.
BRYHALI® (halobetasol) Lotion, 0.01%
Bryhali lotion is intended to treat a variety of common skin conditions including eczema, psoriasis, rash, and so forth. Bryhali is a potent corticosteroid that is intended to reduce swelling, redness, and itching. Bryhali is primarily used to treat the side effects of a number of different skin conditions rather than treating the source.
CLINDAGEL® (clindamycin phosphate gel) Topical Gel, 1%
Clindagel works by fighting the underlying source of acne: inflammation. Unlike many common prescription acne medications, Clingadel utilizes clindamycin in a topical solution that is both effective and highly convenient for patients.
DUOBRII® (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%
Duobrii is intended for adults suffering from psoriasis. With two key ingredients, Duobrii has been proven to be safe and effective for adults of all ages. For patients with acute psoriasis, Duobrii has been proven to be highly efficient at reducing the visible and invisible symptoms of psoriasis.
JUBLIA® (efinaconazole) Topical Solution 10%
Jublia is a topical solution for use in treating common toe fungus. Jublia is formulated to utilize “low surface tension, and the low keratin binding affinity of efinaconazole,” to aid with the delivery of the active ingredient efinaconazole. Unlike many toe fungus solutions, Jublia patients are not required to submit to liver function tests or for physicians to consult with patients regarding liver toxicity.
ONEXTON® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2% / 3.75%
Onexton is approved to treat acne patients aged 12 and older. Onexton is a gel which is formulated without using any alcohol, preservatives, or surfactants. As with many prescription acne treatments, Onexton is most effective used once daily.
RETIN-A MICRO® 0.06% / 0.08% (tretinoin) Gel Microsphere 0.08% / 0.06%
Retin-A Micro is a powerful lesion reduction solution that can be selected in two concentrations: 6 percent or 8 percent for differing patient needs. One of the most appealing aspects of Retin-A Micro is its tolerability for 98.7 percent of patients.
SILIQ® (brodalumab) injection 210 mg/1.5 mL
Siliq is a potent injectable solution for plaque psoriasis sufferers who are non-responsive to other treatments. “In a clinical study, 42% of SILIQ patients achieved 100% clear skin at 12 weeks (vs 0.5% of placebo patients) and 68% of SILIQ patients were totally clear at 52 weeks (vs 0 placebo patients).”
Join Ortho Dermatologics at SCALE 2020 in Nashville!
To learn more about cutting edge cosmetic surgical procedures, non-invasive procedures, laser tech, and much more, join us from July 22-25, 2020 for our annual Music City Scale Conference! SCALE is the premier multidisciplinary meeting for aesthetic medicine, surgery and dermatology in the United States. Join other industry professionals to discuss industry trends, emerging technologies, and much more.
What started as a small gathering amongst colleagues 14 years ago has turned into the biggest party of the year within the field of aesthetic dermatology. Join us alongside hundreds of attendees and industry vendors to find out what you’ve been missing! Click here to see our full, up-to-date list of exhibitors and sponsors for SCALE 2020.
